Other types of follicular lymphoma, unspecified site
ICD-10 C82.80 is a billable code used to indicate a diagnosis of other types of follicular lymphoma, unspecified site.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. It is typically indolent, meaning it progresses slowly, and can present with a variety of symptoms. The unspecified site designation indicates that the lymphoma is not localized to a specific anatomical location, which can complicate treatment and staging. Patients may present with B-symptoms, which include fever, night sweats, and unexplained weight loss. Staging of follicular lymphoma is crucial for determining prognosis and treatment options, typically using the Ann Arbor staging system. Treatment may involve watchful waiting, chemotherapy, immunotherapy, or radiation therapy, depending on the stage and symptoms. The complexity of coding for follicular lymphoma arises from the need to accurately document the type, stage, and symptoms, as well as the treatment plan, to ensure appropriate reimbursement and care management.
Detailed clinical notes on staging, treatment plans, and symptomatology.
Patients presenting with lymphadenopathy, B-symptoms, or those undergoing treatment for follicular lymphoma.
Ensure accurate documentation of all treatment modalities and patient responses.
Histopathological reports confirming diagnosis and subtype.
Biopsy specimens being evaluated for lymphoma classification.
Accurate reporting of histological findings is crucial for correct coding.
Used for patients receiving chemotherapy for follicular lymphoma.
Document the specific chemotherapy regimen and patient response.
Oncology specialists should ensure accurate coding of chemotherapy administration.
Common symptoms include painless swelling of lymph nodes, fever, night sweats, weight loss, and fatigue. Some patients may be asymptomatic.
